Orphic Pharma (India) Limited, a active public limited company, was established on 27 May 2003 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239GJ2003PLC042431. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹3.83 M.
It upholds a compliant status. Its leadership includes Patel Vinodkumar Babarbhai (Director), Sunita Agrawal (Director), Arpit Agrawal (Director). Past directors included Bharatbhai Mansukhbhai Kalavadiya, Anil Baran Hem Lal Debnath, Tushar Mansukhlal Govani. It holds ₹1.06 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 22, Sahjanand Kutir, Munjamahuda Atladra, Vadodara, Gujarat, 390020.
U24239GJ2003PLC042431
042431
27 May 2003
₹1.00 Cr
₹3.83 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Orphic Pharma (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Patel Vinodkumar Babarbhai | Director | 27 May 2003 | Current |
| Sunita Agrawal | Director | 27 May 2003 | Current |
| Arpit Agrawal | Director | 21 Nov 2005 | Current |
| Bharatbhai Mansukhbhai Kalavadiya | Director | 21 Jan 2016 | Current |
| Mansukhlal Ranchhod Govani | Director | 27 May 2003 | Current |
| Vinodbhai Ranchhodbhai Govani | Director | 30 Aug 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2016 | Past |
| Pramod Abcsdd | Director | 30 Aug 2010 | Past |
| Pramod Abcsdd | Director | 21 Jan 2016 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Orphic Pharma (India) Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 0.86% increase. The company also saw a substantial improvement in profitability, with a 103.21% increase in profit. The company's net worth Soared by an impressive increase of 15.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Orphic Pharma (India) had a promoter holding of 57.39% and a public holding of 42.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹10,600,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2025 | Hdfc Bank Limited | ₹1.06 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Orphic Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Orphic Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orphic Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.06 Cr with Charge ID 101136788 was registered on 28 Jul 2025. was documented.
The activity Orphic Pharma (India) Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Orphic Pharma (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
The activity Kamal Khairatilal Batra was appointed as a Director was appointed as a Director on 01 Oct 2022 & has been associated with this company since 3 years 2 months . was completed.
Bharatbhai Mansukhbhai Kalavadiya was appointed as a Director was appointed as a Director on 21 Jan 2016 & has been associated with this company since 9 years 10 months . was recorded as a recent event.
Progress on Vinodbhai Ranchhodbhai Govani was appointed as a Director was appointed as a Director on 30 Aug 2010 & has been associated with this company since 15 years 3 months . was documented.
The CIN of Orphic Pharma (India) Limited is U24239GJ2003PLC042431.
Orphic Pharma (India) Limited is headquartered at Plot No. 22, Sahjanand Kutir, Munjamahuda Atladra, Vadodara, Gujarat, 390020.
Orphic Pharma (India) Limited was incorporated on 27 May 2003.
The current directors of Orphic Pharma (India) Limited are
The primary industry of Orphic Pharma (India) Limited is Manufacturing.
Orphic Pharma (India) Limited is unlisted.
The authorized capital of Orphic Pharma (India) Limited is ₹1.00 Cr, and the paid-up capital is ₹3.83 M.
The compliance status of Orphic Pharma (India) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
_LIMITED.webp)
Company Details
+91-XXXXXXXXXX